although
histori
genom
research
trace
back
develop
dna
sequenc
technolog
review
gene
screen
correspond
author
rappuoli
r
rinorappuoli
novartiscom
wwwdrugdiscoverytodaycom
vaccin
one
effect
tool
prevent
infecti
diseas
avail
complet
genom
sequenc
togeth
progress
highthroughput
technolog
function
structur
genom
led
new
paradigm
vaccin
develop
pangenom
revers
vaccinolog
comparison
sequenc
data
multipl
isol
speci
pathogen
increas
opportun
identif
novel
vaccin
candid
overal
convent
empir
approach
vaccin
develop
replac
vaccin
design
recent
develop
synthet
genom
may
provid
opportun
design
vaccin
new
power
genom
technolog
increas
number
diseas
address
vaccin
decreas
time
discoveri
research
vaccin
develop
infecti
diseas
half
caus
bacteria
remain
lead
caus
death
worldwid
despit
antimicrobi
therapi
emerg
infecti
diseas
event
caus
strain
resist
antimicrobi
etiolog
agent
recent
also
becom
human
pathogen
increas
spectrum
pathogen
present
human
previous
unexpectedli
increas
incid
dozen
new
infecti
diseas
expect
emerg
come
decad
develop
novel
vaccin
diseas
appear
attract
approach
control
prevent
vaccin
one
effect
way
prevent
infecti
diseas
minim
impact
human
popul
basic
paradigm
vaccin
develop
establish
loui
pasteur
end
centuri
ie
isol
inactiv
inject
caus
agent
constitut
foundat
classic
vaccinolog
led
vaccin
develop
throughout
centuri
convent
approach
basi
empir
principl
provid
vaccin
three
major
categori
inactiv
microorgan
livemodifi
agent
subunit
vaccin
compos
purifi
portion
infecti
agent
pathogen
howev
grown
cultur
microorgan
may
requir
specif
sometim
expens
cellcultur
growth
applic
safeti
procedur
may
requir
pathogen
manipul
insuffici
kill
attenu
may
result
presenc
virul
organ
final
vaccin
addit
convent
vaccin
discoveri
approach
timeconsum
could
take
decad
recombin
dna
technolog
use
design
secondgener
vaccin
obtain
ration
attenu
strain
highli
purifi
antigen
compon
exampl
includ
bacteri
toxin
detoxifi
molecular
engin
pertussi
toxin
approach
howev
even
refin
could
requir
year
case
convent
empir
approach
insuffici
find
appropri
solut
develop
univers
vaccin
ie
meningococcu
b
recent
develop
genom
combin
silico
analysi
genom
sequenc
procedur
known
genom
mine
knowledg
function
structur
genom
provid
novel
strategi
rapid
identif
antigen
lead
third
gener
vaccin
genom
revolut
late
mark
begin
socal
genom
era
first
complet
genom
sequenc
freeliv
organ
haemophilu
influenza
sinc
emerg
technolog
allow
sequenc
genom
complet
quickli
past
decad
sequenc
entir
genom
becom
commonli
use
practic
research
besid
bacteri
genom
sever
eukaryot
genom
includ
human
genom
complet
sequenc
genom
studi
genom
organ
whole
postgenom
technolog
investig
rna
transcriptom
protein
proteom
metabolit
metabolom
consider
impact
area
biolog
research
field
vaccinolog
except
rapid
avail
complet
accur
pathogen
genom
sequenc
increas
analysi
tool
avail
mine
biolog
inform
includ
genom
sequenc
remark
decreas
time
vaccin
discoveri
research
develop
fig
genom
mine
made
possibl
predict
gene
potenti
encod
factor
promot
pathogenesi
exampl
basi
sequenc
similar
known
pathogen
protein
alreadi
present
databas
assign
gene
function
predict
featur
encod
protein
cellular
locat
molecular
weight
pi
solubl
regard
revers
vaccinolog
combin
knowledg
compar
experiment
genom
consid
attract
approach
provid
conserv
put
antigen
shortest
possibl
time
moreov
develop
postgenom
approach
acceler
discoveri
factor
relat
pathogenesi
key
element
design
new
vaccin
genom
approach
inde
revolutionari
power
understand
molecular
mechan
diseas
possibl
use
genom
inform
discoveri
potenti
vaccin
candid
lead
new
paradigm
vaccin
develop
fig
approach
refer
revers
vaccinolog
use
genom
sequenc
viral
bacteri
parasit
pathogen
interest
rather
cell
start
materi
identif
novel
antigen
whose
activ
subsequ
confirm
experiment
biolog
gener
aim
identif
gene
potenti
encod
pathogen
factor
secret
membraneassoci
protein
specif
algorithm
suitabl
silico
identif
novel
surfaceexpos
thu
antibodi
access
protein
mediat
protect
respons
use
first
exampl
success
applic
revers
vaccinolog
approach
provid
pizza
cowork
collabor
institut
genom
research
tigr
describ
identif
vaccin
candid
neisseria
meningitidi
serogroup
b
menb
major
caus
sepsi
mening
children
young
adult
convent
approach
obtain
menb
vaccin
fail
decad
mainli
two
reason
first
capsular
polysaccharid
success
use
make
conjug
vaccin
serogroup
resembl
compon
human
tissu
result
poorli
immunogen
human
potenti
abl
induc
autoimmun
respons
second
proteinbas
vaccin
focus
variabl
antigen
confer
protect
limit
number
strain
revers
vaccinolog
approach
start
determin
complet
genom
sequenc
menb
pathogen
strain
sever
comput
tool
use
find
genom
basi
sequenc
featur
presenc
amino
acid
motif
respons
target
matur
protein
outer
membran
signal
peptid
lipid
bilay
lipoprotein
integr
membran
transmembran
domain
recognit
interact
host
structur
analysi
allow
research
identifi
put
surfaceexpos
secret
protein
three
hundr
fifti
protein
express
heterolog
system
escherichia
coli
purifi
use
immun
mice
mice
immun
sera
test
specif
western
blot
access
surfac
bacterium
flow
cytometri
capac
induc
bactericid
antibodi
serum
bactericid
assay
last
mention
test
estim
abil
bactericid
antibodi
evok
complementmedi
lysi
bacteria
case
meningococcu
intern
accept
correl
protect
microorgan
twentynin
surfaceexpos
protein
found
bactericid
select
candid
check
sequenc
conserv
across
panel
strain
repres
genet
divers
meningococcu
includ
clonal
complex
frequent
diseaserel
analysi
allow
select
antigen
abl
elicit
crossbactericid
respons
strain
includ
panel
result
studi
use
set
recent
present
univers
vaccin
neisseria
meningitidi
impact
genom
vaccin
discoveri
research
develop
past
convent
vaccin
discoveri
approach
timeconsum
identif
protect
antigen
took
year
decad
genom
advent
avail
wholegenom
sequenc
highthroughput
technolog
progress
immunolog
provid
novel
strategi
rapid
one
two
year
identif
antigen
dramat
decreas
time
discoveri
research
vaccin
develop
follow
stage
develop
manufactur
vaccin
launch
could
howev
becom
complex
near
futur
result
emerg
new
infecti
diseas
largest
request
safe
effect
cheap
vaccin
major
challeng
still
remain
optim
commerci
aspect
vaccin
develop
due
mainli
increasingli
stringent
regulatori
requir
econom
limit
need
increas
global
prioriti
attribut
vaccin
socioeconom
issu
wwwdrugdiscoverytodaycom
base
cocktail
five
antigen
identifi
revers
vaccinolog
fhbp
nada
vaccin
current
test
phase
ii
clinic
trial
success
revers
vaccinolog
meningococcu
led
applic
approach
varieti
human
pathogen
streptococcu
pneumonia
chlamydia
pneumonia
bacillu
anthraci
porphyromona
gingivali
mycobacterium
tuberculosi
helicobact
pylori
other
tabl
case
identifi
antigen
alreadi
enter
clinic
develop
phase
genomicsbas
studi
also
recent
start
develop
vaccin
virus
avail
small
genom
hepat
c
viru
hcv
recent
possibl
cultiv
vitro
allow
identif
gene
encod
viral
envelop
protein
use
develop
recombin
vaccin
clinic
trial
recent
emerg
sever
acut
respiratori
syndrom
sar
genom
sequenc
respons
agent
coronaviru
rapidli
determin
made
avail
provid
rapid
less
month
identif
protect
vaccin
candid
schemat
imag
main
omic
field
applic
vaccin
discoveri
research
develop
avail
complet
pathogen
genom
sequenc
contemporari
develop
bioinformat
tool
led
new
paradigm
vaccin
develop
wholegenom
sequenc
access
allow
advent
classic
recent
pangenom
revers
vaccinolog
support
molecular
epidemiolog
studi
select
strain
repres
given
pathogen
function
transcriptom
proteom
genom
play
central
role
understand
hostpathogen
interact
structur
genom
atom
resolut
structur
could
provid
basi
ration
engin
potenti
antigen
moreov
recent
time
attend
develop
synthet
genom
area
contribut
andor
potenti
favor
develop
socal
thirdgener
vaccin
select
design
promis
vaccin
candid
take
forward
clinic
trial
virus
human
immunodefici
viru
hiv
develop
effect
vaccin
hamper
high
antigen
divers
pathogen
computerbas
method
use
identifi
sequenc
encod
short
peptid
repres
whole
antigen
divers
potenti
tcell
epitop
construct
protein
use
polyval
vaccin
antigen
evolut
silico
approach
provid
avail
multipl
complet
genom
sequenc
compar
pangenom
revers
vaccinolog
compar
genom
relat
strain
could
consid
progress
classic
revers
vaccinolog
basi
singl
genom
sequenc
predict
put
vaccin
candid
could
use
develop
univers
vaccin
effect
differ
strain
speci
compar
genom
concept
pangenom
year
sinc
first
bacteri
genom
sequenc
publish
complet
microbi
genom
avail
box
one
obviou
conclus
examin
sequenc
bacteri
genom
enorm
amount
divers
even
differ
genom
speci
divers
gener
varieti
mechan
determin
horizont
gene
transfer
includ
mobil
genet
element
like
transpos
element
bacteriophag
concept
genet
divers
intraspeci
signific
interspeci
variat
reveal
subtract
hybrid
compar
genom
hybrid
cgh
studi
isol
belong
bacteri
speci
analyz
microarray
use
sequenc
strain
refer
eg
campylobact
jejuni
escherichia
coli
shigella
studi
show
gene
conserv
strain
speci
extens
genet
divers
cgh
experi
howev
abl
identifi
gene
absent
refer
genom
rapid
develop
sequenc
technolog
provid
complet
genom
sequenc
differ
isol
avail
compar
analys
driven
use
genom
investig
variabl
within
singl
speci
popul
genom
begin
genom
era
genom
avail
belong
mainli
repres
pathogen
strain
differ
speci
avail
huge
amount
sequenc
data
stimul
develop
compar
genom
perform
interspeci
intraspeci
comparison
provid
new
insight
predict
biolog
infecti
diseas
research
compar
genom
basi
power
tool
bioinformat
microarray
technolog
take
advantag
comparison
genom
sequenc
identifi
virul
determin
drug
target
vaccin
candid
instanc
comparison
genom
sequenc
close
relat
pathogen
nonpathogen
bacteria
help
identifi
virul
associ
genet
pattern
tettelin
et
al
introduc
concept
pangenom
defin
global
gene
repertoir
pertain
given
speci
underlin
intraspeci
divers
studi
base
wholegenom
sequenc
comparison
eight
differ
strain
streptococcu
agalactia
group
b
streptococcu
gb
repres
speci
genet
divers
result
show
pangenom
consist
core
gene
share
strain
dispens
gene
absent
least
one
strain
could
much
larger
genom
singl
strain
given
number
uniqu
gene
vast
fact
new
gene
continu
ad
gene
pool
time
new
strain
sequenc
besid
studi
divers
insid
speci
one
possibl
applic
pangenom
vaccinolog
pangenom
revers
vaccinolog
identif
novel
vaccin
candid
target
antimicrobi
maion
colleagu
perform
first
applic
pangenom
vaccin
design
univers
vaccin
gb
comput
algorithm
predict
surfaceassoci
protein
core
gene
remain
gene
absent
least
one
strain
select
potenti
antigen
express
recombin
protein
purifi
test
protect
gb
four
found
elicit
protect
immun
anim
model
among
antigen
one
part
core
genom
howev
abl
confer
global
protect
henc
final
vaccin
formul
includ
combin
four
antigen
gb
exampl
demonstr
multipl
genom
sequenc
speci
import
cover
divers
mani
pathogen
case
highli
differenti
speci
genotyp
variabl
pathogen
could
problem
develop
proteinbas
vaccin
design
cover
wide
panel
strain
popul
vaccinolog
purpos
contribut
molecular
epidemiolog
studi
select
worldwid
repres
strain
cluster
given
microorgan
could
fundament
box
studi
bacteri
gene
express
function
essenti
understand
pathogenesi
interact
pathogen
host
kind
investig
two
main
subfield
genom
function
genom
structur
genom
fig
function
genom
emerg
scientif
field
molecular
biolog
character
develop
largescal
technolog
transcriptom
proteom
contribut
vaccinolog
select
appropri
vaccin
candid
examin
directli
genet
content
transcript
express
profil
transcriptom
provid
overview
overal
transcript
activ
given
pathogen
allow
comparison
gene
express
differ
growth
environment
condit
vaccin
antigen
discoveri
import
know
gene
upregul
vivo
infect
could
repres
protect
vaccin
candid
dna
microarray
technolog
use
studi
gene
express
profil
gene
exampl
use
microarraybas
transcript
profil
identifi
potenti
menb
vaccin
candid
describ
grifantini
et
al
studi
bacteria
incub
human
epitheli
cell
celladh
bacteria
recov
total
rna
purifi
differ
time
parallel
rna
prepar
nonadher
bacteria
grown
absenc
epitheli
cell
two
rna
prepar
compar
analyz
dna
microarray
carri
entir
repertoir
pcramplifi
menb
gene
twelv
protein
whose
transcript
found
particularli
activ
adhes
express
e
coli
purifi
use
produc
antisera
mice
five
sera
show
bactericid
activ
differ
strain
subsequ
transcriptom
analys
show
differenti
regul
gene
also
later
interact
n
meningitidi
endotheli
cell
bloodbrain
barrier
proteom
studi
protein
express
cell
advantag
defin
protein
differenti
express
differenti
locat
exampl
situat
outsid
cell
socal
surfaceom
import
induc
immun
respons
approach
protein
mixtur
first
resolv
individu
compon
use
separ
procedur
like
gel
electrophoresi
liquid
chromatographi
digest
specif
proteas
molecular
mass
peptid
fragment
measur
use
matrixassist
laser
desorptionion
timeofflight
malditof
tandem
mass
spectrometri
msm
peptidemass
fingerprint
use
molecular
epidemiolog
studi
concern
analysi
microevolut
strain
detect
new
emerg
clone
molecular
techniqu
multilocu
sequenc
type
mlst
suitabl
genotyp
identifi
specif
clone
studi
popul
structur
genet
divers
given
microorgan
these
method
allow
identif
frequent
diseaseassoci
clonal
complex
import
also
surveil
diseas
period
year
analysi
relationship
invas
carrier
strain
strain
character
sever
webaccess
databas
develop
rapid
assign
sequenc
type
antigen
variant
provid
tool
molecular
epidemiolog
vaccin
develop
eg
http
wwwmlstnet
develop
univers
vaccin
capabl
induc
protect
wide
spectrum
strain
includ
combin
antigen
molecular
epidemiolog
studi
import
take
account
gener
trend
chang
pathogen
popul
structur
indic
strain
cluster
worldwid
repres
given
microorgan
divers
support
analys
antigen
diversif
within
major
clonal
complex
moreov
molecular
epidemiolog
studi
could
help
monitor
effect
vaccin
introduct
evalu
potenc
occurr
vaccin
escap
variant
appear
novel
pathogen
variant
consequ
strong
select
pressur
impos
databas
search
predict
mass
result
digest
known
protein
classic
proteom
approach
provid
experiment
support
silico
predict
protein
local
alreadi
use
identifi
addit
protein
suitabl
vaccin
compon
exampl
rodriguezortega
et
al
analyz
surfac
proteom
streptococcu
pyogen
group
streptococcu
ga
surfac
digest
live
bacteria
differ
proteas
identifi
protein
express
bacteri
surfac
thu
access
antibodi
fragment
gener
surfac
digest
strain
recov
analyz
msm
spectrometri
identifi
comparison
public
genom
sequenc
novel
possibl
vaccin
target
found
proteom
approach
could
also
consid
complementari
revers
vaccinolog
shown
montigiani
colleagu
case
chlamydia
pneumonia
surfaceexpos
antigen
identif
revers
vaccinolog
approach
mass
spectrometri
analys
map
protein
extract
perform
confirm
presenc
facsposit
antigen
chlamydi
cell
approach
allow
identif
surfaceexpos
protein
suitabl
vaccin
candid
addit
immunoproteom
approach
serolog
proteom
analysi
serpa
combin
proteom
serolog
analysi
use
identifi
potenti
vaccin
candid
exampl
approach
use
vytvytska
collabor
case
staphylococcu
aureu
resolut
surfac
protein
subsequ
electrotransf
onto
membran
blot
differ
serum
pool
human
infect
spot
correspond
immunoreact
protein
analyz
malditof
ms
fifteen
novel
alreadi
known
vaccin
candid
identifi
increas
genom
sequenc
data
also
led
develop
structur
genom
highthroughput
applic
tradit
structur
biolog
basi
experiment
method
xray
crystallographi
nuclear
magnet
reson
nmr
spectroscopi
molecular
electron
microscopi
structur
genom
project
like
solv
provid
highqual
structur
macromolecul
encod
complet
genom
furnish
librari
protein
structur
ultim
goal
complet
view
protein
fold
may
help
assign
function
hypothet
protein
predict
protein
structur
comput
approach
homolog
model
found
similar
known
protein
structur
construct
atomicresolut
model
amino
acid
sequenc
complet
understand
protein
structur
function
studi
function
complex
given
macromolecul
effector
host
facilit
ration
design
drug
vaccin
structur
genom
use
past
two
decad
ration
design
import
chemotherapeut
hiv
influenza
drug
basi
analysi
complex
structur
target
protein
drug
molecul
focus
structur
genom
approach
determin
atomicresolut
crystal
structur
virul
factor
high
prioriti
pathogen
use
develop
vaccin
structur
vaccinolog
studi
structur
antigen
character
viru
envelop
hiv
provid
exampl
applic
structur
vaccinolog
effect
vaccin
must
induc
strong
protect
immun
respons
band
tcell
antibodi
specif
recognit
antigen
epitop
effect
line
defenc
prevent
infecti
diseas
understand
antibodyepitop
interact
establish
basi
ration
design
vaccin
lead
develop
epitopedriven
vaccin
contain
select
epitop
alreadi
describ
exampl
case
cancer
therefor
map
epitop
solv
structur
central
point
ration
vaccin
design
atom
resolut
epitop
howev
requir
high
degre
sophist
expertis
silico
predict
method
capac
acceler
epitop
discoveri
assist
experiment
design
interpret
data
end
import
role
perform
immunoinformat
combin
bioinformat
approach
immunolog
box
provid
tool
lead
new
understand
host
immun
respons
posit
impact
vaccin
develop
global
omic
approach
vaccin
candid
identif
start
knowledg
genom
sequenc
given
pathogen
combin
strategi
mention
role
immunoinformat
epitop
predict
immunoinformat
emerg
applic
bioinformat
techniqu
focus
upon
structur
function
interact
molecul
involv
immun
one
princip
goal
silico
predict
immunogen
level
epitop
set
pathogen
epitop
interfac
host
immun
system
known
immunom
recent
develop
silico
tool
databas
use
identifi
character
predict
antigen
epitop
recogn
tand
blymphocyt
cell
play
signific
role
infect
protect
immun
particular
central
role
perform
tlymphocyt
activ
bcell
growth
differenti
effector
cellmedi
immun
carri
role
need
recogn
peptid
fragment
pathogen
antigen
display
major
histocompat
complex
mhc
protein
surfac
antigenpres
cell
method
model
mhcpeptid
interfac
predict
immunogen
peptid
sequenc
account
tcell
respons
also
known
tcell
epitop
essenti
approach
vaccin
design
avail
entir
pathogen
genom
genomewid
applic
immunogenet
approach
immunogenom
immunoinformat
tool
epitop
map
discoveri
tcell
epitop
acceler
facilit
develop
vaccin
besid
cellular
immun
respons
tcell
adapt
immun
respons
due
antibodysecret
b
lymphocyt
respons
humor
immun
respons
bcell
epitop
defin
discret
surfac
region
antigen
bound
variabl
domain
antibodi
tcell
epitop
short
linear
peptid
bcell
epitop
linear
contigu
amino
acid
discontinu
conform
amino
acid
separ
within
sequenc
brought
togeth
fold
protein
conform
aspect
complic
problem
bcell
epitop
character
predict
sever
bcell
epitop
predict
program
analysi
tool
avail
wwwdrugdiscoverytodaycom
offer
highest
chanc
identifi
best
gene
protein
potenti
interest
vaccin
develop
brief
period
time
key
develop
effect
vaccin
identif
pathogen
compon
often
repres
protein
antigen
elicit
protect
immun
respons
genom
sequenc
annot
provid
list
total
protein
predict
function
local
silico
analysi
repres
first
import
strategi
select
secret
andor
membraneassoci
protein
high
probabl
come
contact
human
immun
system
second
antigen
select
criterion
given
function
genom
provid
qualit
semiquantit
quantit
data
protein
express
allow
comparison
gene
express
differ
growthenvironment
condit
support
furnish
structur
genom
particular
ration
design
target
epitop
use
vaccin
candid
understand
immun
recognit
mechan
approach
show
advantag
limit
tabl
potenti
synergi
offer
combin
genom
technolog
coupl
highthroughput
protein
express
purif
appropri
immunogen
assay
power
repres
concret
effici
approach
vaccin
develop
synthet
genom
new
disciplin
relat
gener
organ
artifici
use
genet
materi
involv
design
assembl
gene
gene
pathway
chromosom
even
whole
genom
combin
method
chemic
synthesi
dna
comput
techniqu
goal
synthet
genom
make
extens
chang
dna
chromosom
assembl
insert
organ
obtain
new
genom
abl
code
new
type
cell
desir
properti
era
synthet
genom
offici
begun
recent
group
j
craig
venter
work
publish
gibson
et
al
describ
multistag
process
construct
complet
genom
mycoplasma
genitalium
first
construct
synthet
genom
encod
live
selfreproduc
organ
provid
mani
potenti
posit
commerci
applic
vaccin
develop
chemic
synthesi
genet
materi
could
involv
creation
new
protein
reduct
cost
protein
engin
structur
analysi
need
anim
model
potenti
lack
method
measur
vitro
efficaci
could
use
pathogen
includ
grown
vitro
lack
inform
gene
express
exhaust
requir
sequenc
multipl
isol
perform
interspeci
intraspeci
comparison
need
crucial
select
repres
strain
given
microorgan
could
use
develop
univers
vaccin
comprehens
direct
correl
mrna
protein
express
level
provid
indic
semiquantit
data
gene
express
infect
give
inform
protein
local
gene
express
regul
transcript
level
identifi
pathogen
factor
requir
high
number
bacteria
proteom
provid
qualit
quantit
data
protein
express
could
identifi
fraction
protein
identifi
membraneassoci
protein
requir
larg
number
bacteria
cell
timeconsum
expens
provid
insight
protein
structur
creat
compar
model
similar
protein
assign
previous
unknown
molecular
function
protein
provid
opportun
recogn
homolog
undetect
sequenc
comparison
practic
limit
compar
model
evolutionarili
relat
protein
consequ
problem
accur
protein
model
case
low
sequenc
similar
less
need
implement
de
novo
protein
structur
predict
uniqu
fold
determin
case
sequenc
diverg
alreadi
protein
data
bank
help
ration
design
target
epitop
use
vaccin
candid
increas
understand
immun
recognit
mechan
structur
genom
effort
often
studi
individu
protein
domain
rather
whole
protein
complex
possibl
rapidli
gener
recombin
vaccin
emerg
microbi
diseas
fig
vaccin
still
repres
one
costeffect
intervent
prevent
infecti
diseas
genom
provid
opportun
vaccin
develop
particular
case
pathogen
tradit
approach
fail
genom
approach
support
advanc
bioinformat
highthroughput
technolog
aris
genom
studi
multipl
antigen
screen
simultan
power
impli
futur
vaccin
discoveri
project
would
strongli
benefit
take
genom
inform
account
confirm
promis
result
offer
revers
vaccinolog
moreov
compar
genom
provid
new
insight
pathogen
evolut
epidemiolog
virul
mechan
host
rang
specif
addit
integr
pathogen
host
genom
like
revolution
approach
develop
safe
effect
vaccin
consid
evolut
offer
structur
genom
synthet
genom
gene
potenti
import
tool
design
futur
vaccin
